GPX4 and acute myeloid leukemia: NRF2 overexpression increases GPX4 levels, and elevated GPX4 correlates with poor prognosis, suggesting that the NRF2–GPX4 axis constitutes a critical ferroptosis evasion strategy in AML [82].